Disease Info Card

Premature Ventricular Contractions

Information about Premature Ventricular Contractions: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Premature Ventricular Contractions

Most recent studies have shown that Premature Ventricular Contractions shares some biological mechanisms with acute-myocardial-infarction, atrial-fibrillation, bradycardia, bundle-branch-block, cardiac-arrhythmia, cardiac-fibrillation, cardiomyopathies, coronary-heart-disease, heart-diseases, heart-failure, infarction, ischemia, myocardial-infarction, myocardial-ischemia, premature-cardiac-complex, sudden-cardiac-death, sudden-death, tachycardia-ventricular, ventricular-arrhythmia, ventricular-fibrillation.

Among the many pathways, these few ones have gauged particular interests from scientists studying Premature Ventricular Contractions, and have been seen in publications frequently: Aging, Cardiac Conduction, Cell Fate Specification, Circadian Rhythm, Coagulation, Excretion, Flight, Innervation, Localization, Mast Cell Degranulation, Pathogenesis, Platelet Aggregation, Reflex, Secretion, Sensitization, Swimming, Transport, Transposition, Vasoconstriction, Vulval Development

Quite a number of genes have been found to play important roles in Premature Ventricular Contractions, such as ACE, CACNA1C, CD3EAP, CFH, DLD, GNL3, GZMA, ITGB2, KRAS, LAD1, PGR, SGSM3, TBXAS1, TMEM37, TYMS, UBN1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.